Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 280 entries
Sorted by: Best Match Show Resources per page
Nanopatterning and Electrical Tuning of MoS2 Layers with a Subnanometer Helium Ion Beam.

Nano letters

Fox DS, Zhou Y, Maguire P, O'Neill A, Ó'Coileáin C, Gatensby R, Glushenkov AM, Tao T, Duesberg GS, Shvets IV, Abid M, Abid M, Wu HC, Chen Y, Coleman JN, Donegan JF, Zhang H.
PMID: 26154305
Nano Lett. 2015 Aug 12;15(8):5307-13. doi: 10.1021/acs.nanolett.5b01673. Epub 2015 Jul 15.

We report subnanometer modification enabled by an ultrafine helium ion beam. By adjusting ion dose and the beam profile, structural defects were controllably introduced in a few-layer molybdenum disulfide (MoS2) sample and its stoichiometry was modified by preferential sputtering...

Cite
Fox DS, Zhou Y, Maguire P, et al. Nanopatterning and Electrical Tuning of MoS2 Layers with a Subnanometer Helium Ion Beam. Nano Lett. 2015;15(8):5307-13doi: 10.1021/acs.nanolett.5b01673.
Fox, D. S., Zhou, Y., Maguire, P., O'Neill, A., Ó'Coileáin, C., Gatensby, R., Glushenkov, A. M., Tao, T., Duesberg, G. S., Shvets, I. V., Abid, M., Abid, M., Wu, H. C., Chen, Y., Coleman, J. N., Donegan, J. F., & Zhang, H. (2015). Nanopatterning and Electrical Tuning of MoS2 Layers with a Subnanometer Helium Ion Beam. Nano letters, 15(8), 5307-13. https://doi.org/10.1021/acs.nanolett.5b01673
Fox, Daniel S, et al. "Nanopatterning and Electrical Tuning of MoS2 Layers with a Subnanometer Helium Ion Beam." Nano letters vol. 15,8 (2015): 5307-13. doi: https://doi.org/10.1021/acs.nanolett.5b01673
Fox DS, Zhou Y, Maguire P, O'Neill A, Ó'Coileáin C, Gatensby R, Glushenkov AM, Tao T, Duesberg GS, Shvets IV, Abid M, Abid M, Wu HC, Chen Y, Coleman JN, Donegan JF, Zhang H. Nanopatterning and Electrical Tuning of MoS2 Layers with a Subnanometer Helium Ion Beam. Nano Lett. 2015 Aug 12;15(8):5307-13. doi: 10.1021/acs.nanolett.5b01673. Epub 2015 Jul 15. PMID: 26154305.
Copy Download .nbib Format: NLM
Dissemination and Adoption of Comparative Effectiveness Research Findings When Findings Challenge Current Practices.

Rand health quarterly

Schneider EC, Timbie JW, Fox DS, Van Busum KR, Caloyeras JP.
PMID: 28083277
Rand Health Q. 2013 Feb 28;2(4):5. eCollection 2013.

Insufficient evidence regarding the effectiveness of medical treatments has been identified as a key source of inefficiency in the U.S. healthcare system. Variation in the use of diagnostic tests and treatments for patients with similar symptoms or conditions has...

Cite
Schneider EC, Timbie JW, Fox DS, et al. Dissemination and Adoption of Comparative Effectiveness Research Findings When Findings Challenge Current Practices. Rand Health Q. 2013;2(4):5
Schneider, E. C., Timbie, J. W., Fox, D. S., Van Busum, K. R., & Caloyeras, J. P. (2013). Dissemination and Adoption of Comparative Effectiveness Research Findings When Findings Challenge Current Practices. Rand health quarterly, 2(4), 5.
Schneider, Eric C, et al. "Dissemination and Adoption of Comparative Effectiveness Research Findings When Findings Challenge Current Practices." Rand health quarterly vol. 2,4 (2013): 5.
Schneider EC, Timbie JW, Fox DS, Van Busum KR, Caloyeras JP. Dissemination and Adoption of Comparative Effectiveness Research Findings When Findings Challenge Current Practices. Rand Health Q. 2013 Feb 28;2(4):5. eCollection 2013. PMID: 28083277; PMCID: PMC5052080.
Copy Download .nbib Format: NLM
The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer.

Cancer research and treatment

Lee JK, Kim DW, Keam B, Kim TM, Lee SH, Kim YJ, Heo DS.
PMID: 25544584
Cancer Res Treat. 2015 Apr;47(2):182-8. doi: 10.4143/crt.2013.227. Epub 2014 Sep 12.

PURPOSE: To investigate the impact of targeted treatment on direct medical costs of patients with advanced non-small cell lung cancer (NSCLC).MATERIALS AND METHODS: Medical records of 108 stage IIIB/IV NSCLC patients treated in Seoul National University Hospital between 2003...

Cite
Lee JK, Kim DW, Keam B, et al. The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer. Cancer Res Treat. 2014;47(2):182-8doi: 10.4143/crt.2013.227.
Lee, J. K., Kim, D. W., Keam, B., Kim, T. M., Lee, S. H., Kim, Y. J., & Heo, D. S. (2015). The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer. Cancer research and treatment, 47(2), 182-8. https://doi.org/10.4143/crt.2013.227
Lee, June-Koo, et al. "The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer." Cancer research and treatment vol. 47,2 (2015): 182-8. doi: https://doi.org/10.4143/crt.2013.227
Lee JK, Kim DW, Keam B, Kim TM, Lee SH, Kim YJ, Heo DS. The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer. Cancer Res Treat. 2015 Apr;47(2):182-8. doi: 10.4143/crt.2013.227. Epub 2014 Sep 12. PMID: 25544584; PMCID: PMC4398109.
Copy Download .nbib Format: NLM
A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer.

Cancer research and treatment

Lee SH, Park K, Suh C, Kim HK, Kim JS, Im YH, Kim SW, Heo DS, Bang YJ, Kim NK.
PMID: 26680912
Cancer Res Treat. 2003 Feb;35(1):30-4. doi: 10.4143/crt.2003.35.1.30.

PURPOSE: A combination of paclitaxel and cisplatin is an effective and safe regimen for advanced non-small cell lung cancer (NSCLC). We conducted a multi-center, phase II trial to evaluate the efficacy and safety of Genexol(R) (paclitaxel) and cisplatin in...

Cite
Lee SH, Park K, Suh C, et al. A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer. Cancer Res Treat. 2003;35(1):30-4doi: 10.4143/crt.2003.35.1.30.
Lee, S. H., Park, K., Suh, C., Kim, H. K., Kim, J. S., Im, Y. H., Kim, S. W., Heo, D. S., Bang, Y. J., & Kim, N. K. (2003). A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer. Cancer research and treatment, 35(1), 30-4. https://doi.org/10.4143/crt.2003.35.1.30
Lee, Se Hoon, et al. "A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer." Cancer research and treatment vol. 35,1 (2003): 30-4. doi: https://doi.org/10.4143/crt.2003.35.1.30
Lee SH, Park K, Suh C, Kim HK, Kim JS, Im YH, Kim SW, Heo DS, Bang YJ, Kim NK. A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer. Cancer Res Treat. 2003 Feb;35(1):30-4. doi: 10.4143/crt.2003.35.1.30. PMID: 26680912.
Copy Download .nbib Format: NLM
Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid.

Annals of surgical treatment and research

Oh SJ, Bae DS, Suh BJ.
PMID: 26029681
Ann Surg Treat Res. 2015 Jun;88(6):345-8. doi: 10.4174/astr.2015.88.6.345. Epub 2015 May 14.

We report an unusual case of synchronous triple primary cancer of the stomach, kidney, and thyroid in a 50-year-old male patient. Initial esophagogastroduodenoscopy with biopsy for the medical check-up revealed poorly differentiated adenocarcinoma. We performed an abdominal/pelvic computed tomography...

Cite
Oh SJ, Bae DS, Suh BJ. Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid. Ann Surg Treat Res. 2015;88(6):345-8doi: 10.4174/astr.2015.88.6.345.
Oh, S. J., Bae, D. S., & Suh, B. J. (2015). Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid. Annals of surgical treatment and research, 88(6), 345-8. https://doi.org/10.4174/astr.2015.88.6.345
Oh, Sung Jin, et al. "Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid." Annals of surgical treatment and research vol. 88,6 (2015): 345-8. doi: https://doi.org/10.4174/astr.2015.88.6.345
Oh SJ, Bae DS, Suh BJ. Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid. Ann Surg Treat Res. 2015 Jun;88(6):345-8. doi: 10.4174/astr.2015.88.6.345. Epub 2015 May 14. PMID: 26029681; PMCID: PMC4443267.
Copy Download .nbib Format: NLM
Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer.

Cancer research and treatment

Joh YH, Kim TY, Na II, Oh DY, Kim BS, Kim JH, Kim DY, Lee SH, Yoo CG, Lee CT, Kim YW, Heo DS, Bang YJ, Han SK, Shim YS, Kim NK.
PMID: 26680810
Cancer Res Treat. 2001 Oct;33(5):373-6. doi: 10.4143/crt.2001.33.5.373.

PURPOSE: Platinum-based chemotherapy has conferred a modest but significant survival benefit and the introduction of newer drugs has led to achieve higher response rate in patients with advanced non-small cell lung cancer (NSCLC). We performed a phase II trial...

Cite
Joh YH, Kim TY, Na II, et al. Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer. Cancer Res Treat. 2001;33(5):373-6doi: 10.4143/crt.2001.33.5.373.
Joh, Y. H., Kim, T. Y., Na, I. I., Oh, D. Y., Kim, B. S., Kim, J. H., Kim, D. Y., Lee, S. H., Yoo, C. G., Lee, C. T., Kim, Y. W., Heo, D. S., Bang, Y. J., Han, S. K., Shim, Y. S., & Kim, N. K. (2001). Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer. Cancer research and treatment, 33(5), 373-6. https://doi.org/10.4143/crt.2001.33.5.373
Joh, Y H, et al. "Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer." Cancer research and treatment vol. 33,5 (2001): 373-6. doi: https://doi.org/10.4143/crt.2001.33.5.373
Joh YH, Kim TY, Na II, Oh DY, Kim BS, Kim JH, Kim DY, Lee SH, Yoo CG, Lee CT, Kim YW, Heo DS, Bang YJ, Han SK, Shim YS, Kim NK. Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer. Cancer Res Treat. 2001 Oct;33(5):373-6. doi: 10.4143/crt.2001.33.5.373. PMID: 26680810.
Copy Download .nbib Format: NLM
Role of antibiotics on surgical site infection in cases of open and laparoscopic cholecystectomy: a comparative observational study.

Journal of surgical technique and case report

Gharde P, Swarnkar M, Waghmare LS, Bhagat VM, Gode DS, Wagh DD, Muntode P, Rohariya H, Sharma A.
PMID: 25013542
J Surg Tech Case Rep. 2014 Jan;6(1):1-4. doi: 10.4103/2006-8808.135132.

INTRODUCTION: Surgical site infection (SSI) comes as third most common healthcare related infection which produces morbidity and deaths at large. Still many authors believe that it is better not to use prophylactic antibiotics in simple and uncomplicated cases. Laparoscope,...

Cite
Gharde P, Swarnkar M, Waghmare LS, et al. Role of antibiotics on surgical site infection in cases of open and laparoscopic cholecystectomy: a comparative observational study. J Surg Tech Case Rep. 2014;6(1):1-4doi: 10.4103/2006-8808.135132.
Gharde, P., Swarnkar, M., Waghmare, L. S., Bhagat, V. M., Gode, D. S., Wagh, D. D., Muntode, P., Rohariya, H., & Sharma, A. (2014). Role of antibiotics on surgical site infection in cases of open and laparoscopic cholecystectomy: a comparative observational study. Journal of surgical technique and case report, 6(1), 1-4. https://doi.org/10.4103/2006-8808.135132
Gharde, Pankaj, et al. "Role of antibiotics on surgical site infection in cases of open and laparoscopic cholecystectomy: a comparative observational study." Journal of surgical technique and case report vol. 6,1 (2014): 1-4. doi: https://doi.org/10.4103/2006-8808.135132
Gharde P, Swarnkar M, Waghmare LS, Bhagat VM, Gode DS, Wagh DD, Muntode P, Rohariya H, Sharma A. Role of antibiotics on surgical site infection in cases of open and laparoscopic cholecystectomy: a comparative observational study. J Surg Tech Case Rep. 2014 Jan;6(1):1-4. doi: 10.4103/2006-8808.135132. PMID: 25013542; PMCID: PMC4090972.
Copy Download .nbib Format: NLM
Feasibility and Outcomes of Laparoscopic Cytoreduction in Patients With Localized Recurrent Epithelial Ovarian Cancer.

Journal of minimally invasive gynecology

Paik ES, Heo EJ, Choi HJ, Yoon A, Lee YY, Choi C, Kim TJ, Lee JW, Kim BG, Bae DS, Choi DS.
PMID: 27679340
J Minim Invasive Gynecol. 2015 Nov-Dec;22(6):S78. doi: 10.1016/j.jmig.2015.08.208. Epub 2015 Oct 15.

No abstract available.

Cite
Paik ES, Heo EJ, Choi HJ, et al. Feasibility and Outcomes of Laparoscopic Cytoreduction in Patients With Localized Recurrent Epithelial Ovarian Cancer. J Minim Invasive Gynecol. 2015;22(6):S78doi: 10.1016/j.jmig.2015.08.208.
Paik, E. S., Heo, E. J., Choi, H. J., Yoon, A., Lee, Y. Y., Choi, C., Kim, T. J., Lee, J. W., Kim, B. G., Bae, D. S., & Choi, D. S. (2015). Feasibility and Outcomes of Laparoscopic Cytoreduction in Patients With Localized Recurrent Epithelial Ovarian Cancer. Journal of minimally invasive gynecology, 22(6), S78. https://doi.org/10.1016/j.jmig.2015.08.208
Paik, E S, et al. "Feasibility and Outcomes of Laparoscopic Cytoreduction in Patients With Localized Recurrent Epithelial Ovarian Cancer." Journal of minimally invasive gynecology vol. 22,6 (2015): S78. doi: https://doi.org/10.1016/j.jmig.2015.08.208
Paik ES, Heo EJ, Choi HJ, Yoon A, Lee YY, Choi C, Kim TJ, Lee JW, Kim BG, Bae DS, Choi DS. Feasibility and Outcomes of Laparoscopic Cytoreduction in Patients With Localized Recurrent Epithelial Ovarian Cancer. J Minim Invasive Gynecol. 2015 Nov-Dec;22(6):S78. doi: 10.1016/j.jmig.2015.08.208. Epub 2015 Oct 15. PMID: 27679340.
Copy Download .nbib Format: NLM
Sub-5 nm graphene nanopore fabrication by nitrogen ion etching induced by a low-energy electron beam.

Nanotechnology

Fox DS, Maguire P, Zhou Y, Rodenburg C, O'Neill A, Coleman JN, Zhang H.
PMID: 27040079
Nanotechnology. 2016 May 13;27(19):195302. doi: 10.1088/0957-4484/27/19/195302. Epub 2016 Apr 04.

A flexible and efficient method to fabricate nanopores in graphene has been developed. A focused, low-energy (5 keV) electron beam was used to locally activate etching of a graphene surface in a low pressure (0.3 Pa) N2 environment. Nanopores...

Cite
Fox DS, Maguire P, Zhou Y, et al. Sub-5 nm graphene nanopore fabrication by nitrogen ion etching induced by a low-energy electron beam. Nanotechnology. 2016;27(19):195302doi: 10.1088/0957-4484/27/19/195302.
Fox, D. S., Maguire, P., Zhou, Y., Rodenburg, C., O'Neill, A., Coleman, J. N., & Zhang, H. (2016). Sub-5 nm graphene nanopore fabrication by nitrogen ion etching induced by a low-energy electron beam. Nanotechnology, 27(19), 195302. https://doi.org/10.1088/0957-4484/27/19/195302
Fox, Daniel S, et al. "Sub-5 nm graphene nanopore fabrication by nitrogen ion etching induced by a low-energy electron beam." Nanotechnology vol. 27,19 (2016): 195302. doi: https://doi.org/10.1088/0957-4484/27/19/195302
Fox DS, Maguire P, Zhou Y, Rodenburg C, O'Neill A, Coleman JN, Zhang H. Sub-5 nm graphene nanopore fabrication by nitrogen ion etching induced by a low-energy electron beam. Nanotechnology. 2016 May 13;27(19):195302. doi: 10.1088/0957-4484/27/19/195302. Epub 2016 Apr 04. PMID: 27040079.
Copy Download .nbib Format: NLM
Pediatric Trigger Digits.

The Journal of hand surgery

Bauer AS, Bae DS.
PMID: 26440744
J Hand Surg Am. 2015 Nov;40(11):2304-9; quiz 2309. doi: 10.1016/j.jhsa.2015.04.041. Epub 2015 Oct 01.

Pediatric trigger thumb presents not at birth but early in childhood. Most evidence suggests that it is caused by a developmental size mismatch between the flexor pollicis longus tendon and its sheath. Patients generally present with the thumb interphalangeal...

Cite
Bauer AS, Bae DS. Pediatric Trigger Digits. J Hand Surg Am. 2015;40(11):2304-9; quiz 2309doi: 10.1016/j.jhsa.2015.04.041.
Bauer, A. S., & Bae, D. S. (2015). Pediatric Trigger Digits. The Journal of hand surgery, 40(11), 2304-9; quiz 2309. https://doi.org/10.1016/j.jhsa.2015.04.041
Bauer, Andrea S, and Bae, Donald S. "Pediatric Trigger Digits." The Journal of hand surgery vol. 40,11 (2015): 2304-9; quiz 2309. doi: https://doi.org/10.1016/j.jhsa.2015.04.041
Bauer AS, Bae DS. Pediatric Trigger Digits. J Hand Surg Am. 2015 Nov;40(11):2304-9; quiz 2309. doi: 10.1016/j.jhsa.2015.04.041. Epub 2015 Oct 01. PMID: 26440744.
Copy Download .nbib Format: NLM
Electrochemical Performances of Yttrium Doped Li3V(2-X)Y(X)(PO4)3/C Cathode Material for Lithium Secondary Battery.

Journal of nanoscience and nanotechnology

Jeong M, Kim HS, Bae DS, Lee CW, Jin BS.
PMID: 26726460
J Nanosci Nanotechnol. 2015 Oct;15(10):8042-7.

In this study, the Li3V(2-X)Y(X)(PO4)3 compounds have been synthesized by a simple solid state method. In addition, a polyurethane was added to apply carbon coating on the surface of the Li3V(2-X)Y(X)(PO4)3 particles for enhancement of the electrical conductivity. The...

Cite
Jeong M, Kim HS, Bae DS, et al. Electrochemical Performances of Yttrium Doped Li3V(2-X)Y(X)(PO4)3/C Cathode Material for Lithium Secondary Battery. J Nanosci Nanotechnol. 2015;15(10):8042-7
Jeong, M., Kim, H. S., Bae, D. S., Lee, C. W., & Jin, B. S. (2015). Electrochemical Performances of Yttrium Doped Li3V(2-X)Y(X)(PO4)3/C Cathode Material for Lithium Secondary Battery. Journal of nanoscience and nanotechnology, 15(10), 8042-7.
Jeong, Minchan, et al. "Electrochemical Performances of Yttrium Doped Li3V(2-X)Y(X)(PO4)3/C Cathode Material for Lithium Secondary Battery." Journal of nanoscience and nanotechnology vol. 15,10 (2015): 8042-7.
Jeong M, Kim HS, Bae DS, Lee CW, Jin BS. Electrochemical Performances of Yttrium Doped Li3V(2-X)Y(X)(PO4)3/C Cathode Material for Lithium Secondary Battery. J Nanosci Nanotechnol. 2015 Oct;15(10):8042-7. PMID: 26726460.
Copy Download .nbib Format: NLM
Plasmachemical surface functionalised beads: versatile tailored supports for polymer assisted organic synthesis.

Chemical communications (Cambridge, England)

Badyal JP, Cameron AM, Cameron NR, Coe DM, Cox R, Davis BG, Oates LJ, Oye G, Spanos C, Steel PG.
PMID: 15179485
Chem Commun (Camb). 2004 Jun 21;(12):1402-3. doi: 10.1039/b401329h. Epub 2004 May 14.

Plasmachemical surface modification of porous polystyrene beads with allylamine or diaminopropane provides reactive amine functionality exclusively at accessible surface sites, allowing faster reactions than classically prepared materials.

Cite
Badyal JP, Cameron AM, Cameron NR, et al. Plasmachemical surface functionalised beads: versatile tailored supports for polymer assisted organic synthesis. Chem Commun (Camb). 2004;(12):1402-3doi: 10.1039/b401329h.
Badyal, J. P., Cameron, A. M., Cameron, N. R., Coe, D. M., Cox, R., Davis, B. G., Oates, L. J., Oye, G., Spanos, C., & Steel, P. G. (2004). Plasmachemical surface functionalised beads: versatile tailored supports for polymer assisted organic synthesis. Chemical communications (Cambridge, England), (12), 1402-3. https://doi.org/10.1039/b401329h
Badyal, Jas Pal, et al. "Plasmachemical surface functionalised beads: versatile tailored supports for polymer assisted organic synthesis." Chemical communications (Cambridge, England) vol. ,12 (2004): 1402-3. doi: https://doi.org/10.1039/b401329h
Badyal JP, Cameron AM, Cameron NR, Coe DM, Cox R, Davis BG, Oates LJ, Oye G, Spanos C, Steel PG. Plasmachemical surface functionalised beads: versatile tailored supports for polymer assisted organic synthesis. Chem Commun (Camb). 2004 Jun 21;(12):1402-3. doi: 10.1039/b401329h. Epub 2004 May 14. PMID: 15179485.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 280 entries